Excited to announce that in August we dosed our first patient in the BEAM-201 trial!
This is the first patient treated for Beam and the first patient in the US treated with a base editing therapeutic.
https://t.co/ZwK6aRxEEA
Here's a 1-minute video showing--in the words of visualization hero @EdwardTufte--the "compared to what" factor for today's amazing @NASAWebb image. Thanks to the @WWTelescope for making this possible, and @ADavidWeigel. I only wish @NASA and @POTUS had shown the image this way!
#OTD in 2011, our #Cassini spacecraft took in this view of Saturn’s rings seen edge on, casting broad shadows on the planet’s cloud tops. Two moons, Epimetheus and Enceladus, can also be seen just below the ring plane, dwarfed by the immense planet. More: https://t.co/Og09brBKV5
Congratulations to our fearless leader & CEO @john_evans3 for being recognized as New England's 2020 Entrepreneur of the year by @EY_US! We are all cheering you on in the national round and I am so proud to be mentored under your leadership! #EOYUS#EOYNE
https://t.co/daYb3n5NDE
I just received this email from one of the largest hospitals in MA @BrighamWomens, calling for donations of RNA isolation kits. “We have all of the elements we need to launch the test except for viral RNA isolation kits.“ @QIAGEN@Roche: Please help!🙏https://t.co/hJYic02GDd
Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in clinical trials. Also, we accidentally found the first-ever inhibitor of the cyclin-dependent kinase CDK11. https://t.co/Rthvr67cyk
@TerrificBRoth At home, I pour the cream in first so the coffee mixes it as it pours over the cream. Never understood why everyone doesn’t do it that way.